Error message

The page you requested does not exist. For your convenience, a search was performed using the query events thu 17 jan 0930 systemic anticancer therapy these talks are aimed first year phd students all.

Search results

  1. Dr Catherine Lindon

    ... role of substrate proteolysis in the precisely coordinated events giving rise to two daughter cells at the end of mitosis. The Aurora ...

  2. Dr Athena Matakidou

    ... modify the mouse renal apithelium and replicate the genetic events observed in human renal cell carcinoma. The development of reproducible ...

  3. Dr Mariann Bienz

    ... cell compartment. Our aim is to understand the molecular events underlying Wnt signal transduction. We focus on positively-acting ...

  4. Dr Dario Bressan

    ... for the spatial and temporal control of biological events in vivo. Specifically, I am using photochemically caged ligands and ...

  5. Dr Frank McCaughan

    My research is focused on understanding the early driver events that are critical to the development of squamous lung cancer (SQC) and ...

  6. Professor Gillian Murphy

    ... by trafficking which allows specific localisation in events such as cell invasion. The identification of the importance of specific ...

  7. Dr James Nathan

    Cellular mechanisms of oxygen and metabolite sensing: ...

  8. Dr James Rudd

    ... arteries as a predictor of plaque rupture and clinical events. Additionally, I use non-invasive imaging methods such as PET, MRI and ...

  9. Ms Paola Marco

    ... The inhibitor can be washed out, allowing us to study events in a more flexible way. I will introduce these mutants in RPE cells to ...

  10. Dr Marisa Segal

    ... morphogenesis in S. cerevisiae we have focused on the events that determine SPB asymmetry or spindle polarity, i.e. the mechanisms ...

  11. Dr David Gilligan

    David Gilligan is a Consultant Clinical Oncologist at Addenbrooke's and Papworth Hospitals in Cambridge. He is the Clinical Lead for Acute Oncology at Addenbrooke's. He trained in pre clinical medicine at the University of Edinburgh and clinical...

  12. Mr David Thurtle

    Radiological assessment of prostatic osseous metastases. Robotic-assisted laparoscopic prostatectomy. Early detection of prostate cancer. Risk Prediction in prostate cancer

  13. Professor David Glover

    Our laboratory studies the regulation of progression through mitosis and meiosis in animal cells. The high degree of evolutionary conservation of these regulatory mechanisms means that findings in model organisms are readily applicable to human cells....

  14. Dr Roisin Owens

    Our group works on integrating biological models with electronic devices to generate systems that can be predictive of real biological systems, for drug discovery and therapeutics. We combine expertise in a wide range of disciplines including...

  15. Mr Thierry Lefebvre

    Radiotherapy is often prescribed in oncology clinics to treat solid tumours and to limit the development and the propagation of cancer cells. The lack of oxygenation seen in some tumour regions under chaotic and unrestricted cellular growth constitute a...

  16. Professor Walid Khaled

    My laboratory works on defining the early cellular and molecular events that drive tumour initiation and development. In particular, we focus on how the cell of origin affects the differentiation trajectory of nascent tumour cells and dictates changes...

  17. Mr Adam Palmer

  18. Mrs Angela Godoy

  19. Dr Adrian Kelly

    Biology of MHC class I and class II antigen processing and presentation pathways.

  20. Professor Tony Green

    Tony Green is Professor of Haemato-oncology in the University of Cambridge and honorary Consultant Haematologist at Addenbrookes Hospital. He was appointed Head of the University Department of Haematology (2000-2020), and in 2016 was appointed Director...

  21. Dr Alex Samoshkin

    I have been a Translational Technology Manager in the University of Cambridge since 2017. My primary role is to connect researchers in technology/physical sciences with clinicians and academics to develop new collaborative translational projects. I...

  22. Dr Chiwen Chang

    1. Interaction between NK cells and HLA Class I antigen during immune response. 2. Immunotherapy for cancers and autoimmune diseases.

  23. Dr Christopher Shepherd

  24. Professor Charlotte Coles

    Charlotte Coles is Professor of Breast Cancer Clinical Oncology and NIHR Research Professor at the CRUK Cambridge Centre. Her research aims are to provide breast cancer patients with the best chance of cure with least side effects by personalising...

  25. Professor David Rubinsztein

  26. Dr Elizabeth Soilleux

  27. Dr Alejandra Bruna

    We aimed to study the effects of the TGF-beta pathway in breast cancer stem cell (BCSC) regulation. To define a role of the TGF-beta pathway in the regulation of human BCSCs, we have analyzed a panel of breast cancer cell lines that represent the...

  28. Dr Danish Mazhar

    Dr Mazhar was a Medical Undergraduate at the University of Oxford and completed his Clinical Training in London. He undertook Specialist Training in Medical Oncology at the Hammersmith and Charing Cross Hospitals in London. He was awarded a PhD by...

  29. Mr Giuseppe Aresu

    Mr Aresu is a Consultant Thoracic Surgeon at the Royal Papworth Hospital. He undertook his Cardiothoracic specialist training in Padua, Udine (Italy) and in Bristol (UK). In November 2011 he started working as consultant thoracic surgeon in Udine where...

  30. Mrs Jane Bushen

  31. Mrs Jane Lichfield

  32. Dr Jane Dobson

    As a Veterinary Oncologist, I am interested in many aspects of cancer including diagnostic methods and treatment of commonly occuring cancers in animals eg lymphoma and osteosarcoma. Animals cancer patients could provide an excellent model for...

  33. Dr Janet Maguire

  34. Dr Jan Czarnecki

  35. Dr Ljiljana Fruk

  36. Dr Paul Lyons

    ... to the clinical management of autoimmune diseases such as systemic lupus erythematosus and small vessel vasculitis. This approach will ...

  37. Professor Randall Johnson

    ... homeostasis, including pulmonary vascular tension and even systemic blood pressure.  We have found that this control is highly related to ...

  38. Dr Trevor Littlewood

    The use of classical, germ-line genetics to define gene function in vertebrates is severely limited by embryonic lethality, developmental compensation and adaptive functional degeneracy, all of which obscure the roles played by genes in adult tissues...

  39. Dr Will Ince

    ... prostate and recurrent/metastatic head and neck cancer with systemic treatments  Improving approaches to personalised radiotherapy in ...

  40. Dr Bristi Basu

    ... or show potential as early predictors for efficacy of anticancer drugs. ...

  41. Professor Ian Paterson

    Organic synthesis - generally related to anticancer natural products and analogues. Synthesis of potent cytotoxic ...

  42. Dr Jon Houseley

    ... across the landscape to malignant cells facing targeted anticancer drugs, adaptation is required for survival. We question how new ...

  43. Dr Richard Baird

    ... funded by:  - Cancer Research UK  - EU HORIZON 2020 - AntiCancer Fund - AstraZeneca  - Boehringer-Ingelheim - Genentech - ...

  44. Dr Andrew Gee

    Since 1995, I have been working on technical aspects of clinical ultrasonic imaging, with particular emphasis on three-dimensional imaging and elastography (stiffness imaging). Along with Richard Prager and Graham Treece, I lead the Medical Imaging...

  45. Dr Andre Neves

    ... cancer diagnosis and for better assessing response to cancer therapy. Currently, I'm planning a first-in-human clinical trial of a novel ...

  46. Dr Richard Benson

    Interests based around improving radiotherapy and chemoradiotherapy in head and neck and urological cancers, develpoing technical radiotherapy and evaluating treatment related toxicity.

  47. Professor Bertie Gottgens

    ... blood stem/progenitor cell populations used in cell and gene therapy protocols. ...

  48. Professor Kevin Brindle

    ... techniques to detect the early responses of tumours to therapy, with a view to translating these into clinical application. This has ...

  49. Dr Camilo Colaco

    Developing cancer therapy as opposed to research. Autologous tumour-dendritic cell fusion hybrids ...

  50. Dr Camilo Colaco

  51. Dr Christopher Jones

    My research focuses on improving the radiation response and post-radiation monitoring of oesophageal cancers, with a particular focus on oesophageal adenocarcinoma. I am also interested in the study of radiotherapy-related genomic evolution.

  52. Dr Claire Connell

    Pancreatic cancer and immunotherapy

  53. Dr Ahsan MEMON

    ... cell behaviours through cell signaling. Ever since, these findings have directly led to expanding and redefining understanding of ... modulator to generate multi-depth multi-chromatic holograms. These holograms are produced through a custom-developed iterative code with ...

  54. Dr Adrian Ionescu

    ... up a strong track record with international recognition in these research areas, with 50 publications and two books to date. With some of these publications I have helped shape the new interdisciplinary field of ...

  55. Professor Andrew Flewitt

    ... thin film piezoelectrics. There are two applications of these. Surface acoustic wave (SAW) devices can be used to make microfluidic ...

  56. Dr Alasdair Russell

    ... model systems in a pre-clinical setting. Further, we use these novel models in a range of pre-clinical trials to advance our ...

  57. Mr Angelos Kolias

    ... and evaluation of PET-guided surgery for pituitary adenomas. These are collaborative projects with Mr Richard Mannion (Clinical Lead for ...

  58. Professor Anna Philpott

    ... a disease of differentiation. Ultimately, our studies on these fundamental mechanisms that co-ordinate proliferation and differentiation ...

  59. Professor Anthony Davenport

    ... imaging using positron emission tomography, to determine how these are altered with disease. Major interests are the role of endothelin-1 in ...

  60. Dr Alex Cagan

    ... our own bodies are constantly acquiring mutations. Some of these mutations may influence cellular phenotypes, such as growth, resulting in ... Over time our bodies become a patchwork of clones. These processes drive cancer progression and may contribute to ageing.  Due to ...

  61. Professor Ben Simons

    ... epidermal maintenance in mouse. Currently, we are extending these ideas to explore cell fate in human epidermis addressing both normal and malignant tissue. These investigations are pursued in close collaboration with experimentalists ...

  62. Dr Basma Greef

    ... of hypoxia response pathways in renal cancer and how these can be harnessed to develop new treatments. My other interests include ...

  63. Dr Andreas Bender

    ... to the prediction of adverse drug reactions. In case you are generating large amounts of chemical or biological data related to cancer drug discovery you are very welcome to contact me to see in which way I could contribute to your ...

  64. Professor Antonis Antoniou

    ... and the development of risk prediction tools which are used in clinical practice. I have a research group of 10 which focuses on ...

  65. Professor Adrian Liston

    We are focussed on understanding the biology of regulatory T cells within the ...

  66. Dr Ashray Gunjur

    I am an early-career medical oncologist from Melbourne, Australia. I am broadly interested in immuno-oncology and the link between cancer and the gut microbiome, and am undertaking a PhD supervised by Dr David Adams and Dr Trevor Lawley (Wellcome...

  67. Miss Amara Cañizares

  68. Dr Fazlur Rahman Talukdar

    ... (IARC-WHO), France, in 2015. During this tenure, my research aimed to identify DNA methylome alterations linked to esophageal cancer within ...

  69. Dr Kerstin Meyer

    ... analysis of predisposition loci: My experiments are aimed at understanding the mechanisms by which breast cancer risk loci ...

  70. Dr Misha Kapushesky

    ... a universal ecosystem for bioinformatics development, aimed to reduce the chaotic clutter of inefficiency and incompatibility in ...

  71. Dr Nicholas Walton

    ... currently aiding in their search for new techniques aimed at the treatment of breast cancer. ...

  72. Professor Rahul Roychoudhuri

    ... providing targets for development of new therapies aimed at reversing dysfunctional immune responses in cancer. ...

  73. Dr Sujath Abbas

    ... I developed a cost-effective DNA sequencing method (mutREAD) aimed for screening of mutational signatures using FFPE DNA, envisioning its ...

  74. Professor Tim Eisen

    ... where I am currently responsible for oncology trials from first in man to Phase II. ...

  75. Dr Elisa Laurenti

    ... As perturbation of HSC regulatory networks drives the first steps of leukaemia, knowledge of HSC specific molecular responses will ...

  76. Dr Kelly Holmes

    ... CRUK Cambridge Centre Imaging Programme Manager. Kelly has a first class degree in Biochemistry with a year in industry. She completed her ...

  77. Professor Duncan Jodrell

    ... therapies and novel therapeutic combinations, including first into man (phase I) and associated studies.  My research goal is to ...

  78. Dr Laura Blackburn

    ... research and held a workshop on the implementation of the first ctDNA testing services in the NHS, which were facilitating treatment ...

  79. Dr Lori Passmore

    ... of translation to control gene expression, and is the first step in mRNA turnover. The major deadenylase activities are found within ...

  80. Dr Aisling Redmond

    Aisling received her undergraduate degree in Genetics from Trinity College Dublin and PhD from Dublin City University. She completed postdoctoral fellowships in the breast cancer field at the Royal College of Surgeons in Ireland and Cancer Research UK...

  81. Dr David Adams

    ... data for over 200 genetically modified mouse lines per year to gain a better understanding of mammalian gene function. ...

  82. Dr Daniel Hodson

    Pathogenesis of Germinal Centre Derived B Cell Lymphomas. Many of the commonest human lymphomas (including follicular, diffuse large B cell and Burkitt lymphomas) develop from a specific stage of B lymphocyte differentiation termed the Germinal Centre. ...

  83. Dr Joanna Baxter

    The Cambridge Blood and Stem Cell Biobank is a facility of over 6000 viable and nucleic acid samples, the majority from patients with haematological malignancy and clonal blood cell disorders; and the remainder, around 20%, from normal individuals,...

  84. Mrs Eva Serrao

    Despite medical advances, pancreatic cancer still has a 5-year survival rate of less than 6%. The ideal way to improve this is to ...

  85. Dr Hayley Woffendin

    After many years working as a postdoctoral research scientist (Molecular Biologist) within the University and Wellcome Trust Sanger Institute, I have been Scientific Administrator and Graduate Student Administrator with the Department of Oncology Since...

  86. Dr Hannah Harrison

    Since moving into public health research around 5 years, Hannah has been involved in projects investigating risk-stratification for kidney cancer screening and follow-up. Her most rencet project, funded by CRUK, is investigating multifactorial models...

  87. Dr Adrien Hallou

    ... approaches of biological systems during my MPhil and PhD in Biophysics at the University of Cambridge. I am now a Research Fellow at ...

  88. Dr Amos Burke

    ... and currently co-supervises a Clinical and a basic science PhD student. At a national level Dr Burke is the National Institute for Health ...

  89. Miss Annalisa Occhipinti

    I am a Mathematician and I am doing a PhD in bioinformatics at the University if Cambridge. I am currently working on ...

  90. Dr Cedric Ghevaert

    ... the Royal College of Pathologists in 2005. He obtained his PhD in 2008 studying novel antibodies for the treatment of bleeding in neonates ...

  91. Ms Ceilidh Welsh

    I am a PhD student working with  Cancer Research UK RadNet Cambridge Radiation ...

  92. Dr Emmanuel Huguet

    ... undergraduate medical students. He subsequently undertook a PhD in cancer molecular biology at Oxford University in the laboratories of the ...

  93. Professor Eamonn Maher

    ... and non-clinician scientists and had supervised more than 25 PhD or MD students to completion. Current research in Eamonn?s group relates to ...

  94. Professor Vincent Gnanapragasam

    Vincent J Gnanapragasam holds a personal Chair in Urology at the University of Cambridge and is an Honorary Consultant Urologist at Addenbrooke’s Hospital, Cambridge. He graduated from Newcastle University and following basic surgical training, was...

  95. Mr Arqum Anwar

    Rotation Project: The project aims to investigate the cellular role(s) of a novel factor expected to be involved in DNA damage response. Specifically, the interactome of the protein will be explored using co-immunoprecipitation followed by mass...

  96. Ms Alison Hallett

  97. Dr Allanah Barker

Pages